Ketorolac Tromethamine Hospira

Short-term (≤5 days) management of moderately severe acute pain that requires analgesia at opioid level, usually in post-op setting.

IV/IM Adult Max: 5 days. Multiple-dose treatment Patient ≥65 yr, renal impairment & those weighing <50 kg 15 mg every 6 hr. Max daily dose: 60 mg, <65 yr 30 mg every 6 hr. Max daily dose: 120 mg. IM Single-dose treatment Patient ≥65 yr, renal impairment & those weighing <50 kg 30 mg as single dose, <65 yr 60 mg as single dose. IV Single-dose treatment Patient ≥65 yr, renal impairment & those weighing <50 kg 15 mg as single dose, <65 yr 30 mg as single dose.

Hypersensitivity. Severe, rarely fatal, anaphylactic-like reactions to NSAIDs. Not to be given in patients who have experienced asthma, urticaria or allergic-type reactions after taking aspirin or other NSAIDs. Patients w/ active PUD, recent GI bleeding or perforation & history of PUD or GI bleeding. Prophylactic analgesic before any major surgery. CABG surgery. Patients w/ advanced renal impairment or those at risk for renal failure due to vol depletion. Intra-op when hemostasis is critical because of increased bleeding risk. Patients w/ suspected or confirmed cerebrovascular bleeding, hemorrhagic diathesis, incomplete hemostasis & those at high bleeding risk. Patients currently receiving aspirin or NSAIDs. Concomitant use w/ probenecid & pentoxifylline. Neuraxial (epidural or intrathecal) administration due to alcohol content. Labor & delivery. Lactation.

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

M01AB15 - ketorolac ; Belongs to the class of acetic acid derivatives and related substances of non-steroidal antiinflammatory and antirheumatic products.

POM